Atlas Trials

(CLONEVO): Cell cycLe inhbitiON to Target the EVolution of UrOthelial Cancer

Clinical trial NCT03837821 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT03837821
Sponsor
Weill Medical College of Cornell University
Status
ACTIVE_NOT_RECRUITING
Phase
Early Phase 1
Study type
INTERVENTIONAL
Bladder Cancer
Start date
2019-02-05
Primary completion
2024-07-02
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.